FDA Drugs recall ·
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle… recall
- Recall number
- D-0575-2025
- Date
- (initiated July 29, 2025)
- Company / brand
- Pfizer Inc.
66 Hudson Blvd, Manhattan, NY, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 29, 004 bottles
- Hazard tags
- Potency
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Why was it recalled?
Subpotent drug
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: 24C11, Exp 2/28/2026.
Distribution
Within U.S
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0575-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.